The first 88-liter active ingredient used to make AstraZeneca’s coronavirus vaccine arrived in Brazil from China on Saturday, which is crucial to accelerating the country’s troubled vaccination program.
According to the report, with the arrival of vaccine production materials, Brazil’s Fiocruz Biomedical Center can start filling and complete the production of 2.8 million doses of vaccine.
The federally funded center is expected to receive more raw materials this month to produce a total of 15 million vaccines developed with Oxford University.
The Fiocruz production line, originally scheduled to start production in December, has been idle due to the delay in obtaining the first batch of supplies from China.
AstraZeneca’s vaccine is the core pillar of Brazil’s national vaccination program, and the federal government has ordered the raw materials for Fiocruz production, which can produce up to 100 million doses.